Green Market Report: Judge Not Swayed in Battle Over Epidiolex Patents

Teva Pharmaceuticals sued Jazz Pharmaceuticals (NASDAQ: JAZZ) over the patents for the cannabis drug Epidiolex which is used to treat rare pediatric epilepsy conditions known as Lennox-Gastaut syndrome, Davaut syndrome, and tuberous sclerosis complex. However, a judge has rejected the argument that Jazz wasn’t truthful when applying for the patents.

Read the full report

Primary Sponsor


Karma Koala Podcast

Top Marijuana Blog